Salesforce was among the investors that backed the virtual health service’s latest round, helping it take its funding to $216m altogether.
US-based virtual care workforce provider Wheel secured $150m in series C funding yesterday from investors including enterprise software provider Salesforce as telehealth services continue to thrive during the covid-19 pandemic.
Venture capital firm Lightspeed Venture Partners and investment firm Tiger Global Management co-led the round, which included Coatue Management, CRV, Tusk Venture Partners and Silverton Partners, bringing the company’s total funding to $216m.
Founded in 2018 as Enzyme Health, Wheel has built a remote healthcare service that helps clinicians and other medical care providers virtually deliver services including urgent, behavioural, paediatrics and chronic condition care management as well as consumer diagnostics.
The company will use the cash to further improve its software tool in a bid to offer more customised digital care to end-users, in addition to increasing its white-labelled diagnostic offerings, enabling patients to access testing and follow-up care.
Michelle Davey, Wheel’s chief executive and co-founder, said in a…
